Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Quanta Dialysis Partners With B. Braun To Support Home Hemodialysis Care

Quanta Dialysis has signed an agreement with B. Braun to provide support services to Quanta’s patients in the UK. The hemodialysis firm launched its compact hemodialysis device SC+ on the market at the beginning of the year.

Renal Commercial Companies

Companies

Set Alert for Companies

Latest From Companies

J&J Has Big Plans For Robotic Surgery In 2020

The company’s leadership discussed its recent investments in robotic surgery technology during Johnson & Johnson’s 2019 fourth-quarter earnings call on 22 January. The company will provide more information on its robotic surgery platforms at its investors meeting in May in New York.

Robotic Surgery Companies

Smith & Nephew Boosts ENT Portfolio, Acquires Tusker Medical

Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.

Ear Ear, Nose & Throat

GE Monitoring Station Vulnerability Could Let Hackers Turn Off Critical Patient Alarms

US regulators and GE have notified health-care providers that the company’s nurse bay monitoring stations could be attacked by malicious hackers to turn off critical alarms that are intended to alert caregivers when a patient is in a critical state.

Cybersecurity Safety
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Smith & Nephew Boosts ENT Portfolio, Acquires Tusker Medical

Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.

Ear Ear, Nose & Throat

QUOTED. 10 January 2020. Francis deSouza.

Illumina Inc. has agreed to pay $98m to terminate its merger agreement with Pacific Biosciences of California Inc. following opposition from antitrust regulators in the US and UK. See what Illumina CEO Francis deSouza said about it here.

Quoted Deals

Illumina Pays Pacific Biosciences $98M To Terminate $1.2Bn Merger Deal

Illumina had planned to acquire Pacific Biosciences to add the company's “long-read” gene sequencing systems to Illumina's own range of "short-read" technologies. However, the UK’s Competition and Markets Authority and the US Federal Trade Commission concluded that the deal would significantly reduce competition in the DNA sequencing market.

Deals M & A
See All

Market Access

Set Alert for Market Access

Latest From Market Access

US Senate Approves US-Mexico-Canada Agreement Championed By Industry

The US Senate overwhelmingly approved a bill on 16 January to implement the US-Mexico-Canada agreement, which includes a new chapter on the handling of medical devices supported by the medtech industry.

Policy Trade

Former Palliative-Care Firm CEO Brad Smith Appointed Head Of CMS Innovation Center

Brad Smith, the former CEO of Aspire Health, a home-based palliative-care company, was appointed director of the Center for Medicare and Medicaid Innovation (CMMI) at the US Medicare agency CMS.

Policy Appointments

Medtronic Wins In England’s NICE Decision On Implantable Monitors For Stroke Patients; Biotronik And Abbott Lose

UK health technology assessment body NICE says that Medtronic’s Reveal LINQ, which transmits data remotely to doctors, is likely to be a cost-effective use of National Health Service resources.

Health Technology Assessment United Kingdom
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Device Week, 2 January 2020 – Most-Read Market Intelligence Stories In 2019; Insulin Pumps in 2020

In this edition of Device Week, Medtech Insight's deputy editor Reed Miller chats with managing editor Marion Webb about the most popular Market Intel stories in 2019 and next-generation insulin pumps expected to be introduced in 2020.

Device Week Market Intelligence

The Top 5 Market Intel Stories Of 2019: A Mixed Bag Of Hemodialysis, Robotics, Ophthalmology, Femtech And Liquid Biopsy

A look back at Medtech Insight’s five most-read Market Intelligence features of 2019 reveals a diverse mix of interests among our readers – hemodialysis, robotic surgeries, ophthalmic surgical solutions, liquid biopsy and digital technologies that seek to improve women's health.

Market Intelligence Companies

Market Brief: Robotic Surgery Systems Market Will Reach $9.7Bn By 2023; Driven By Innovation, Procedure Volume Growth And Access To Emerging Markets

The global market for robotic surgery systems is expected to grow at a CAGR of 16%, reaching $9.7bn by 2023, driven by continued innovation, access to emerging markets and rising demand. 

Market Intelligence Robotics
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: Google Cloud COO Heads To Neural Analytics; Promotions And New Appointments At Exactech & Zimmer

Neural Analytics, a maker of a robotically assisted ultrasound system, hires Google Cloud COO as chairman and CEO; Exactech, a developer of ortho implants and surgical instrumentation, promotes senior VP to CEO and president; Zimmer Biomet, a dental and spinal-implants maker, appoints new communications chief; and more.

Commercial Appointments

Execs On The Move: An Eli Lilly President Departs; Finance Positions Filled At NuVasive And DBV Technologies

The president of Eli Lilly USA departs for CEO post at FibroGen, a developer of medicines for anemia, fibrotic disease and cancer; a former Mallinckrodt exec is CFO of NuVasive, a maker of products for spine surgery; DBV Technologies, an investigator of treatments for food allergies, also adds a CFO; and more.

Commercial Appointments

Former Palliative-Care Firm CEO Brad Smith Appointed Head Of CMS Innovation Center

Brad Smith, the former CEO of Aspire Health, a home-based palliative-care company, was appointed director of the Center for Medicare and Medicaid Innovation (CMMI) at the US Medicare agency CMS.

Policy Appointments
See All
UsernamePublicRestriction

Register